As a Managing Director at Blue Owl Healthcare Opportunities, Tim Anderson sources and executes investments in biotechnology, diagnostics, and digital medicine. He was a co-founding member of Cowen Healthcare Investments, the predecessor to Blue Owls current strategy, and previously worked as a biotechnology investment banker. He holds a bachelors degree from Bowdoin College.
He currently serves on the Board of Directors for multiple companies, including Windward Bio, Nuvig Therapeutics, Lycia Therapeutics, and Autobahn Therapeutics.